St. Valentine’s Day is fast approaching, and romantic types who can’t get enough of all things travel-related are dreaming of ...

Acadian Timber Corp. (“Acadian” or the “Company”) (TSX:ADN) today reported financial and operating results1 for the three ...

The VA wants to eliminate redundant central office roles and empower hospital directors to run their operations in the best interest of patients.

The expansion of the Universe, discovered nearly a century ago by Edwin Hubble, shows that galaxies are moving away from us faster the more distant they are. Yet, our nearest neighbor, the ...

For more than a century, astronomers have watched in astonishment as the Andromeda galaxy ignored the grand flow of cosmic ...

The Nike Structure Plus is a stability shoe done right. ZoomX adds softness while ReactX keeps things controlled, and the support feels subtle rather than restrictive. It’s comfortable, versatile and ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. After the ...

The Bermuda Triangle may not be the biggest mystery of the Atlantic. In a new study published in the journal Geophysical Research Letters, scientists believe they have discovered the reason why ...

Anchor your business to a stubborn, real-world problem customers cannot ignore. Replace hustle with systems that standardize decisions, data flow and accountability. Ambition isn’t what holds ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...